Literature DB >> 15466274

Management of lupus nephritis: an update.

Frédéric A Houssiau1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15466274     DOI： 10.1097/01.ASN.0000140218.77174.0A

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  13 in total

1.  Lupus nephritis in Chinese children--a territory-wide cohort study in Hong Kong.

Authors:  Sik-Nin Wong; Kei-Chiu Tse; Tsz-Leung Lee; Kwok-Wai Lee; Stella Chim; Kwok-Piu Lee; Reann Wai-Po Chu; Winnie Chan; Kwok-Wah Fong; Joannie Hui; Samantha Po-Siu Li; Pa-Shing Yeung; So-Fun Yuen; Assunta Chi-Hang Ho; Lettie Chuk-Kwan Leung; David Luk; Pak-Chiu Tong; Shu-Yan Chan; Hon-Ming Cheung; Chung-Mo Chow; David Lau
Journal:  Pediatr Nephrol       Date:  2006-04-26       Impact factor: 3.714

2.  Defining the role of mycophenolate mofetil in the treatment of proliferative lupus nephritis.

Authors:  Oliver Lenz; Alessia Fornoni; Gabriel Contreras
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Serum uric acid levels are associated with lupus nephritis in patients with normal renal function.

Authors:  Ana Luisa Calich; Eduardo Ferreira Borba; Michelle Remião Ugolini-Lopes; Luiza Fuoco da Rocha; Eloisa Bonfá; Ricardo Fuller
Journal:  Clin Rheumatol       Date:  2018-01-20       Impact factor: 2.980

4.  [Lupusnephritis].

Authors:  M Haubitz
Journal:  Z Rheumatol       Date:  2012-12       Impact factor: 1.372

5.  Rituximab in severe lupus nephritis: early B-cell depletion affects long-term renal outcome.

Authors:  Catherine Melander; Marion Sallée; Pierre Trolliet; Sophie Candon; Xavier Belenfant; Eric Daugas; Phillipe Rémy; Virginie Zarrouk; Evangéline Pillebout; Christian Jacquot; Jean-Jacques Boffa; Alexandre Karras; Virginie Masse; Philippe Lesavre; Caroline Elie; Isabelle Brocheriou; Bertrand Knebelmann; Laure-Hélène Noël; Fadi Fakhouri
Journal:  Clin J Am Soc Nephrol       Date:  2009-03-04       Impact factor: 8.237

Review 6.  Treatment options for proliferative lupus nephritis: an update of clinical trial evidence.

Authors:  Sankar D Navaneethan; Gautham Viswanathan; Giovanni F M Strippoli
Journal:  Drugs       Date:  2008       Impact factor: 9.546

7.  Urine proteome scans uncover total urinary protease, prostaglandin D synthase, serum amyloid P, and superoxide dismutase as potential markers of lupus nephritis.

Authors:  Tianfu Wu; Yuyang Fu; Deirdre Brekken; Mei Yan; Xin J Zhou; Kamala Vanarsa; Nima Deljavan; Chul Ahn; Chaim Putterman; Chandra Mohan
Journal:  J Immunol       Date:  2010-01-11       Impact factor: 5.422

Review 8.  Lupus nephritis.

Authors:  Hans-Joachim Anders; Ramesh Saxena; Ming-Hui Zhao; Ioannis Parodis; Jane E Salmon; Chandra Mohan
Journal:  Nat Rev Dis Primers       Date:  2020-01-23       Impact factor: 52.329

9.  Urine VCAM-1 as a marker of renal pathology activity index in lupus nephritis.

Authors:  Sandeep Singh; Tianfu Wu; Chun Xie; Kamala Vanarsa; Jie Han; Tina Mahajan; Ho Bing Oei; Chul Ahn; Xin J Zhou; Chaim Putterman; Ramesh Saxena; Chandra Mohan
Journal:  Arthritis Res Ther       Date:  2012-07-13       Impact factor: 5.156

10.  Geographical distribution, a risk factor for the incidence of lupus nephritis in China.

Authors:  Qingjun Pan; Yaning Li; Ling Ye; Zhenzhen Deng; Lu Li; Yongmin Feng; Weijing Liu; Huafeng Liu
Journal:  BMC Nephrol       Date:  2014-05-01       Impact factor: 2.388
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.